Glaukos

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Glaukos and other ETFs, options, and stocks.

About GKOS

Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology.

CEO

Thomas William Burns

CEOThomas William Burns

Employees

727

Employees727

Headquarters

San Clemente, California

HeadquartersSan Clemente, California

Founded

1998

Founded1998

Employees

727

Employees727

GKOS Key Statistics

Market cap

2.54B

Market cap2.54B

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

481.82K

Average volume481.82K

High today

$55.89

High today$55.89

Low today

$53.23

Low today$53.23

Open price

$53.52

Open price$53.52

Volume

480.22K

Volume480.22K

52 Week high

$64.49

52 Week high$64.49

52 Week low

$33.33

52 Week low$33.33

Analyst ratings

56%

of 9 ratings

Buy

33.3%

Hold

55.6%

Sell

11.1%

GKOS Earnings

-$0.83

-$0.55

-$0.28

$0.00

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Nov 3, After Hours

ActualExpected Nov 3, After Hours